Company Filing History:
Years Active: 2011
Title: Innovations of Huiyu Cao in Cancer Research
Introduction
Huiyu Cao is an accomplished inventor based in Cohoes, NY (US). She has made significant contributions to the field of cancer research through her innovative work. Her research focuses on the role of prostaglandin-endoperoxide H synthase (PGHS-2) in cancer cells, leading to the development of potential therapeutic agents.
Latest Patents
Huiyu Cao holds a patent for "Inhibitors of PGHS-2 Transactivator activity." This invention explores a previously undisclosed transcriptional function of PGHS-2, which is known to convert arachidonic acid to prostaglandin H. PGHS-2 is typically undetectable in most normal human tissues but is abundant in cancer cells. The patent outlines a method that includes a DNA binding assay to evaluate PGHS-2 protein binding to specific regions of the PGHS-2 promoter in the presence and absence of test compounds. This method aims to identify inhibitors of PGHS-2 transactivation activity, which could be useful in treating cancer.
Career Highlights
Huiyu Cao has established herself as a leading figure in her field. Her work at the Ordway Research Institute, Inc. has allowed her to collaborate with other prominent researchers, enhancing the impact of her inventions.
Collaborations
Some of her notable coworkers include Hung-Yun Lin and Paul J. Davis. Their collaborative efforts have contributed to advancing research in cancer treatment and understanding the mechanisms involved.
Conclusion
Huiyu Cao's innovative work in cancer research, particularly her patent on PGHS-2 transactivator inhibitors, showcases her dedication to finding new therapeutic agents. Her contributions are vital in the ongoing fight against cancer, and her collaborations further enhance the potential impact of her research.